Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

Background: Hepatitis A vaccine has been used in mass and routine public vaccination programs in China. Long-term follow-up studies are required to determine the duration of protection and the need for booster vaccinations. Methods: A prospective, randomized, open-label clinical trial was performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yongji, Qi, Yangyang, Xu, Wenguo, Hu, Yuansheng, Wang, Ling, Yu, Yongpei, Jiang, Zhiwei, Xia, Jielai, Zeng, Gang, Wang, Yalong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644183/
https://www.ncbi.nlm.nih.gov/pubmed/32040376
http://dx.doi.org/10.1080/21645515.2020.1715687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644183/
https://www.ncbi.nlm.nih.gov/pubmed/32040376
http://dx.doi.org/10.1080/21645515.2020.1715687

Ejemplares similares